table of content
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnostic Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnostic Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnostic Tests Overall Market Size
2.1 Global Lung Cancer Diagnostic Tests Market Size: 2021 VS 2028
2.2 Global Lung Cancer Diagnostic Tests Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnostic Tests Players in Global Market
3.2 Top Global Lung Cancer Diagnostic Tests Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnostic Tests Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnostic Tests Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Diagnostic Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnostic Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Lung Cancer Diagnostic Tests Market Size Markets, 2021 & 2028
4.1.2 Immunoassays
4.1.3 Flow Cytometry
4.1.4 Rapid Tests
4.1.5 Molecular Assays
4.1.6 Tissue Arrays
4.1.7 Circulating Tumor Cells
4.1.8 Pharmacodiagnostics
4.1.9 Biomarkers
4.1.10 Other Diagnostics Methods
4.2 By Type - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnostic Tests Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Diagnostic Tests Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnostic Tests Market Size, 2021 & 2028
5.1.2 Precision Medicine
5.1.3 Personalized Medicine
5.1.4 Cancer Monitoring
5.2 By Application - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnostic Tests Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Diagnostic Tests Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnostic Tests Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnostic Tests Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Diagnostic Tests Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.3.2 US Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.3.3 Canada Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.3.4 Mexico Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.4.2 Germany Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.3 France Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.4 U.K. Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.5 Italy Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.6 Russia Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.7 Nordic Countries Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.8 Benelux Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.5.2 China Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.3 Japan Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.4 South Korea Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.5 Southeast Asia Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.6 India Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.6.2 Brazil Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.6.3 Argentina Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.7.2 Turkey Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7.3 Israel Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7.4 Saudi Arabia Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7.5 UAE Lung Cancer Diagnostic Tests Market Size, 2017-2028
7 Players Profiles
7.1 Advpharma Inc
7.1.1 Advpharma Inc Corporate Summary
7.1.2 Advpharma Inc Business Overview
7.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Major Product Offerings
7.1.4 Advpharma Inc Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.1.5 Advpharma Inc Key News
7.2 AIT Austrian Institute of Technology GmbH
7.2.1 AIT Austrian Institute of Technology GmbH Corporate Summary
7.2.2 AIT Austrian Institute of Technology GmbH Business Overview
7.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Major Product Offerings
7.2.4 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.2.5 AIT Austrian Institute of Technology GmbH Key News
7.3 Courtagen Life Sciences Inc
7.3.1 Courtagen Life Sciences Inc Corporate Summary
7.3.2 Courtagen Life Sciences Inc Business Overview
7.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Major Product Offerings
7.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.3.5 Courtagen Life Sciences Inc Key News
7.4 DiagnoCure Inc. (Inactive)
7.4.1 DiagnoCure Inc. (Inactive) Corporate Summary
7.4.2 DiagnoCure Inc. (Inactive) Business Overview
7.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Major Product Offerings
7.4.4 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.4.5 DiagnoCure Inc. (Inactive) Key News
7.5 BioMark Diagnostics Inc.
7.5.1 BioMark Diagnostics Inc. Corporate Summary
7.5.2 BioMark Diagnostics Inc. Business Overview
7.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Major Product Offerings
7.5.4 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.5.5 BioMark Diagnostics Inc. Key News
7.6 BioMarker Strategies LLC
7.6.1 BioMarker Strategies LLC Corporate Summary
7.6.2 BioMarker Strategies LLC Business Overview
7.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Major Product Offerings
7.6.4 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.6.5 BioMarker Strategies LLC Key News
7.7 Emory University
7.7.1 Emory University Corporate Summary
7.7.2 Emory University Business Overview
7.7.3 Emory University Lung Cancer Diagnostic Tests Major Product Offerings
7.7.4 Emory University Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.7.5 Emory University Key News
7.8 Epigenomics AG
7.8.1 Epigenomics AG Corporate Summary
7.8.2 Epigenomics AG Business Overview
7.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Major Product Offerings
7.8.4 Epigenomics AG Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.8.5 Epigenomics AG Key News
7.9 GlycoZym
7.9.1 GlycoZym Corporate Summary
7.9.2 GlycoZym Business Overview
7.9.3 GlycoZym Lung Cancer Diagnostic Tests Major Product Offerings
7.9.4 GlycoZym Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.9.5 GlycoZym Key News
7.10 HalioDx SAS
7.10.1 HalioDx SAS Corporate Summary
7.10.2 HalioDx SAS Business Overview
7.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Major Product Offerings
7.10.4 HalioDx SAS Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.10.5 HalioDx SAS Key News
7.11 Louisville Bioscience, Inc.
7.11.1 Louisville Bioscience, Inc. Corporate Summary
7.11.2 Louisville Bioscience, Inc. Business Overview
7.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Major Product Offerings
7.11.4 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.11.5 Louisville Bioscience, Inc. Key News
7.12 Mayo Clinic US
7.12.1 Mayo Clinic US Corporate Summary
7.12.2 Mayo Clinic US Business Overview
7.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Major Product Offerings
7.12.4 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.12.5 Mayo Clinic US Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
